We are live on
!
Find out more
IVMX
Institutional Venture Management XVI Portfolio holdings
AUM
$1.18M
1-Year Est. Return
156.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.16%
1 Year Est. Return
+156.01%
3 Year Est. Return
+522.88%
5 Year Est. Return
+246.9%
10 Year Est. Return
–
AUM
$317M
AUM Growth
-$17.9M
(-5.4%)
Cap. Flow
-$71.6M
Cap. Flow
% of AUM
-22.54%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
2
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$27.9M |
| 2 |
Hims & Hers Health
HIMS
|
+$21.9M |
| 3 |
Datadog
DDOG
|
+$17.2M |
| 4 |
NXDR
Nextdoor Holdings
NXDR
|
+$4.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 68.64% |
| 2 | Healthcare | 24.09% |
| 3 | Financials | 4.46% |
| 4 | Consumer Discretionary | 2.82% |
| 5 | Communication Services | 0% |
Similar funds
JBFJ
CLIC
GFWEX
YU
S3G1
SL
SGIHM
LFA
Institutional Venture Management XVI's Q1 2023 Portfolio in Review
As of Q1 2023, Institutional Venture Management XVI held 8 positions worth $317M, down 5.4% from $335M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Institutional Venture Management XVI withdrew a net $71.6M in Q1 2023, closing 2 positions and reducing 2 holdings. Its most notable exit was UiPath, an estimated $27.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 69% of assets, down from 73% a quarter earlier, followed by Healthcare and Financials.
- Institutional Venture Management XVI's biggest Q1 2023 reduction was Hims & Hers Health, cutting an estimated $21.9M.
- Institutional Venture Management XVI fully exited UiPath in Q1 2023, selling an estimated $27.9M.
- Institutional Venture Management XVI's ten largest holdings make up 100% of its $317M portfolio in Q1 2023.
- Institutional Venture Management XVI opened 0 new positions and closed 2 in Q1 2023.
- Institutional Venture Management XVI's portfolio value fell 5.4% quarter-over-quarter to $317M.
Based on Institutional Venture Management XVI's 13F filing for Q1 2023, filed 15 May 2023.